Abbott Laboratories (ABT) – Market Snapshot (Wednesday, 21 Oct 2026)

Trading Session

  • Close time: 06:45 AM Central Europe
  • Price movement: down 0.79 %
  • Current price: USD 104.06

Volume and Liquidity

  • Shares outstanding: 1.7 bn
  • Trading volume (last 24 h): USD 837.1 mn
  • Average daily volume: not specified

Valuation Metrics

  • Market capitalization: USD 181.5 bn
  • Price‑to‑earnings ratio (P/E): not provided
  • 200‑day simple moving average: USD 102.70
  • 52‑week high: USD 132.03 (18 Nov 2025)
  • 52‑week low: USD 81.97 (11 May 2026)

Recent Performance

  • Monthly change: +1.05 % since the end of the last month

SymbolCompanyPrice ChangeCurrent PriceMarket CapitalizationP/E Ratio
DISWalt Disney /The0.00 %USD 111.67USD 191 bn22.79
CCitigroup-2.07 %USD 122.51USD 205.7 bn12.15
APHAmphenol+1.17 %USD 79.32USD 195.7 bn39.89
AXPAmerican Express+0.90 %USD 318.34USD 211.8 bn19.02
GILDGilead Sciences-2.00 %USD 156.51USD 193.7 bn–

Company Overview

Abbott Laboratories is a U.S.-based health‑care equipment and supplies company headquartered in Abbott Park, United States. The company discovers, develops, manufactures, and sells a diversified portfolio of products and services, including pharmaceuticals, nutritionals, diagnostics, and vascular products. Abbott markets its products globally through affiliates and distributors. The company’s website is www.abbott.com , and it trades on the New York Stock Exchange.


Summary

As of the close on 21 Oct 2026, Abbott Laboratories traded at USD 104.06, a decline of 0.79 % from the previous session. The stock is priced above its 200‑day moving average and remains within its 52‑week trading range. Market capitalization stands at USD 181.5 bn, with a significant daily volume of USD 837.1 mn. Related peer stocks displayed a mix of gains and losses, reflecting broader market dynamics.